Satellos Bioscience Inc. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported net loss was CAD 11.32 million compared to CAD 15.51 million a year ago. Basic loss per share from continuing operations was CAD 0.32 compared to CAD 0.64 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.47 CAD | +2.17% | +17.50% | +9.30% |
27/03 | Satellos Bioscience Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
27/03 | Satellos Bioscience Announces FY 2023 Results | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.30% | 38.8M | |
+3.91% | 109B | |
+10.87% | 105B | |
0.00% | 22.25B | |
-13.14% | 22.09B | |
-8.10% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- MSCL Stock
- News Satellos Bioscience Inc.
- Satellos Bioscience Inc. Reports Earnings Results for the Full Year Ended December 31, 2022